Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018
- PMID: 32270198
- PMCID: PMC8326549
- DOI: 10.1093/cid/ciaa407
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018
Abstract
Background: Demonstration of influenza vaccine effectiveness (VE) against hospitalized illness in addition to milder outpatient illness may strengthen vaccination messaging. Our objective was to compare patient characteristics and VE between United States (US) inpatient and outpatient VE networks.
Methods: We tested adults with acute respiratory illness (ARI) for influenza within 1 outpatient-based and 1 hospital-based VE network from 2015 through 2018. We compared age, sex, and high-risk conditions. The test-negative design was used to compare vaccination odds in influenza-positive cases vs influenza-negative controls. We estimated VE using logistic regression adjusting for site, age, sex, race/ethnicity, peak influenza activity, time to testing from, season (overall VE), and underlying conditions. VE differences (ΔVE) were assessed with 95% confidence intervals (CIs) determined through bootstrapping with significance defined as excluding the null.
Results: The networks enrolled 14 573 (4144 influenza-positive) outpatients and 6769 (1452 influenza-positive) inpatients. Inpatients were older (median, 62 years vs 49 years) and had more high-risk conditions (median, 4 vs 1). Overall VE across seasons was 31% (95% CI, 26%-37%) among outpatients and 36% (95% CI, 27%-44%) among inpatients. Strain-specific VE (95% CI) among outpatients vs inpatients was 37% (25%-47%) vs 53% (37%-64%) against H1N1pdm09; 19% (9%-27%) vs 23% (8%-35%) against H3N2; and 46% (38%-53%) vs 46% (31%-58%) against B viruses. ΔVE was not significant for any comparison across all sites.
Conclusions: Inpatients and outpatients with ARI represent distinct populations. Despite comparatively poor health among inpatients, influenza vaccination was effective in preventing influenza-associated hospitalizations.
Keywords: attenuation; hospitalization; influenza; severity; vaccine effectiveness.
Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Figures

Similar articles
-
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).Clin Infect Dis. 2022 Apr 28;74(8):1329-1337. doi: 10.1093/cid/ciab654. Clin Infect Dis. 2022. PMID: 34320171 Free PMC article.
-
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016.Influenza Other Respir Viruses. 2020 Jul;14(4):380-390. doi: 10.1111/irv.12741. Epub 2020 Apr 16. Influenza Other Respir Viruses. 2020. PMID: 32298048 Free PMC article.
-
Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.Hum Vaccin Immunother. 2015;11(7):1626-33. doi: 10.1080/21645515.2015.1038002. Hum Vaccin Immunother. 2015. PMID: 25996366 Free PMC article.
-
Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16.Euro Surveill. 2018 Jan;23(2):16-00780. doi: 10.2807/1560-7917.ES.2018.23.2.16-00780. Euro Surveill. 2018. PMID: 29338809 Free PMC article.
-
Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.Vaccine. 2018 Feb 28;36(10):1272-1278. doi: 10.1016/j.vaccine.2018.01.045. Vaccine. 2018. PMID: 29402578 Free PMC article.
Cited by
-
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020.Clin Infect Dis. 2021 Dec 6;73(11):e4244-e4250. doi: 10.1093/cid/ciaa1884. Clin Infect Dis. 2021. PMID: 33367650 Free PMC article.
-
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).Clin Infect Dis. 2022 Apr 28;74(8):1329-1337. doi: 10.1093/cid/ciab654. Clin Infect Dis. 2022. PMID: 34320171 Free PMC article.
-
Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale.PLoS One. 2021 Oct 21;16(10):e0258482. doi: 10.1371/journal.pone.0258482. eCollection 2021. PLoS One. 2021. PMID: 34673782 Free PMC article.
-
Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons.Vaccine. 2022 Dec 12;40(52):7703-7708. doi: 10.1016/j.vaccine.2022.11.011. Epub 2022 Nov 12. Vaccine. 2022. PMID: 36379754 Free PMC article.
-
Cost-effectiveness of seasonal influenza vaccination in WHO-defined high-risk populations in Bangladesh.J Glob Health. 2024 Jul 19;14:04126. doi: 10.7189/jogh.14.04126. J Glob Health. 2024. PMID: 39024624 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Disease burden of influenza. Available at: https://www.cdc.gov/flu/about/burden/index.html. Accessed 27 December 2019.
-
- Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2018–19 influenza season. Available at: https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm. Accessed 27 December 2019.
-
- Belongia EA, Simpson MD, King JP, et al. . Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 2016; 16:942–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical